The Toxicity of Cytarabine
- 1 January 1990
- journal article
- review article
- Published by Springer Nature in Drug Safety
- Vol. 5 (1) , 7-27
- https://doi.org/10.2165/00002018-199005010-00003
Abstract
The principal toxicity of standard induction regimens for acute non-lymphocytic leukaemia (ANLL) [including cytarabine (ARA-C) 100 mg/m2for 7 days plus an anthracycline] is myelotoxicity, leading to...Keywords
This publication has 98 references indexed in Scilit:
- High‐dose ARA‐C (HiDAC) plus asparaginase in elderly patients with acute non‐lymphocytic leukemia: A pilot multicentric study by the Italian cooperative group GIMEMAEuropean Journal of Haematology, 1989
- Intermediate and high dose Ara-C and m-AMSA for remission induction and consolidation treatment of patients with acute myeloid leukemia: an EORTC leukemia cooperative group phase II studyEuropean Journal of Cancer and Clinical Oncology, 1988
- Severe Persistent Cerebellar Dysfunction Complicating Cytosine Arabinoside TherapyActa Medica Scandinavica, 1988
- High risk of streptococcal septicemia after high dose cytosine arabinoside treatment for acute myelogenous leukemiaJournal of Molecular Medicine, 1987
- Antiemetic Therapy in Patients Treated with High-Dose Cytosine ArabinosideOncology, 1987
- Effect of cytosine arabinoside on the human immunosystem: Toxicity against quiescent human peripheral blood mononuclear cells in vitroInternational Journal of Immunopharmacology, 1987
- Adult Respiratory Distress Syndrome in Patients with Severe NeutropeniaNew England Journal of Medicine, 1986
- Acute Meningitis and Cerebellar Dysfunction Complicating High‐dose Cytosine Arabinoside TherapyActa Medica Scandinavica, 1986
- Subacute pulmonary failure complicating therapy with high-dose ara-C in acute leukemiaCancer, 1985
- Transport and Phosphorylation as Factors in the Antitumor Action of Cytosine ArabinosideScience, 1967